Recombinant expression and properties of the Kunitz‐type protease‐inhibitor module from human type VI collagen α3(VI) chain
- 1 October 1994
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 225 (2), 573-580
- https://doi.org/10.1111/j.1432-1033.1994.00573.x
Abstract
The Kunitz-type inhibitor motif (domain C5) present at the C-terminus of the human collagen alpha 3(VI) chain was prepared in a recombinant form from the culture medium of stably transfected kidney cell clones. The 76-residue protein was disulfide bonded and showed a high stability against protease treatment. The recombinant protein lacked, however, any inhibitory activity for trypsin, thrombin, kallikrein and several other proteases, which could be due to a few unusual substitutions in the region crucial for inhibitor binding. A sensitive radioimmunoassay detected low concentrations of C5 epitopes in normal human serum and fibroblast culture medium and showed a lack of cross-reaction with aprotinin. Antibodies against C5 immunoprecipitated collagen VI obtained from fibroblast medium. The C5 epitopes could not be detected on intact collagen VI purified from guanidine extracts of human placenta. Collagen VI was shown to possess several alpha 3(VI) chain bands (approximately 200 kDa) and reacted strongly with antibodies to an N-terminal recombinant fragment. Immunofluorescence with anti-C5 antibodies failed to stain several human tissues but produced a distinct intracellular staining of cultured fibroblasts. The data indicate the rapid loss of the C5 domain after biosynthesis of collagen VIKeywords
This publication has 34 references indexed in Scilit:
- The carboxyl-terminal half of type VII collagen, including the non-collagenous NC-2 domain and intron/exon organization of the corresponding region of the COL7A1 geneHuman Molecular Genetics, 1993
- High level expression, purification, and characterization of the Kunitz-type protease inhibitor domain of protease nexin-2/amyloid β-protein precursorBiochemical and Biophysical Research Communications, 1992
- Natural protein proteinase inhibitors and their interaction with proteinasesEuropean Journal of Biochemistry, 1992
- Recombinant expression and properties of the human calcium‐binding extracellular matrix protein BM‐40European Journal of Biochemistry, 1991
- Calcium‐dependent binding of basement membrane protein BM‐40 (osteonectin, SPARC) to basement membrane collagen type IVEuropean Journal of Biochemistry, 1991
- X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid .beta.-protein precursorBiochemistry, 1990
- Does the Kunitz domain from the Alzheimer's amyloid β protein precursor inhibit a kallikrein responsible for post‐translational processing of nerve growth factor precursor?FEBS Letters, 1990
- Protease-specificity of Kunitz inhibitor domain of Alzheimer's disease amyloid protein precursorBiochemical and Biophysical Research Communications, 1990
- Cloning and complete amino acid sequences of human and murine basement membrane protein BM‐40 (SPARC, osteonectin)FEBS Letters, 1988
- Protein Inhibitors of ProteinasesAnnual Review of Biochemistry, 1980